TL;DR
- Idea: Decentralized science protocol enabling community-driven funding, liquidity, and AI-driven research through tokenized BioDAOs
- Catalyst: Recent V2 upgrade on Base and Solana with BioAgents launchpad; trending search interest on CoinGecko; active ecosystem growth
- Risks: Regulatory risks in biotech funding; reliance on protocol governance adoption; token unlock schedule may pressure price
- Score: 7.00/ 10
Coin
- Name/ Ticker: Bio Protocol (BIO)
- Segment: DeSci
- Status: active
- Price: $0.030600
Key Metrics
- Market Cap: $54 012 170
- FDV: $101 325 506
- Circulating Supply: 1 769 745 956
- Total Supply: 3 320 000 000
Sources
Technology
- USP: AI-powered BioAgents for automated research and funding flow
- Core Technology: Decentralized Launchpad, veBIO governance, BioXP incentive engine, onchain BioAgents
Roadmap
- 2024-12-23: Listed on Binance Launchpool
- 2025-03-21: Bio V1 Mainnet Launch
- 2025-09-17: $6.9M Funding & Bio V2 Launch
Team & Investors
Team
- Co-Founder — Paul Kohlhaas: 10+ years in DeFi tokenomics and protocol design
- Legal Counsel — Jose Pinto: Specialist in crypto regulation and compliance
- AI Lead — Ritvik Singh: Former Google AI researcher, leads BioAgents development
- AI Research — Johannes Weniger: Expert in LLM integration for scientific workflows
- Marketing — Alex Dobrin: Ex-Chainlink CMO with 8 years in crypto marketing
Investors
- Maelstrom Fund — Seed • 2025-09-17 • $6.90M
- Mechanism Capital — Seed • 2025-09-17
- Animoca Brands — Seed • 2025-09-17
- Presto Labs — Seed • 2025-09-17
- Enterprise Investors — Enterprise • 2024-08-19
Total funding: $13.12M
Tokenomics
- Utility: Staking for governance and launch access, funding new BioDAOs, providing liquidity, paying for BioAgents services
- Vesting: Team: 1-year cliff then 6-year linear vest; Investors: 1-year cliff then 4-year linear vest
Pros & Cons
Strengths
- First-mover in decentralized science funding
- Strong AI infrastructure with BioAgents
- Backing by top crypto funds
- Multi-chain interoperability (Ethereum, Base, Solana)
- Active ecosystem with BioDAOs and partnerships
Weaknesses
- Regulatory uncertainty in biotech
- High complexity for new users
- Token unlock schedule may increase sell pressure
- Reliance on DAO governance participation
- Competition from traditional biotech funding models
Market Signals (7d)
- TVL trend: increasing
- CEX volume trend: increasing
- Active addresses trend: increasing
Price Scenarios (target: 2026-10-16)
- Bear: $0.010000 — Based on 7-day low support level and conservative adoption estimates
- Base: $0.050000 — Projection using 3-month moving average growth and stable TVL expansion
- Bull: $0.100000 — Assumes 2x TVL growth and increased institutional adoption
How to Buy & Store
CEX
- Binance
- OKX
- Gate
- KuCoin
- Bitget
DEX
- Uniswap V3 (Base)
- Jupiter (Solana)
- PancakeSwap (BSC)
- 1inch
- SushiSwap
Storage
- MetaMask
- Coinbase Wallet
- Ledger
- Trezor
- Trust Wallet
Verdict
Bio Protocol is a pioneering DeSci protocol with strong technological differentiation and solid fund backing. While regulatory and adoption risks remain, rising ecosystem engagement and multi-chain support justify a medium-term bullish outlook.
Official Links
Source: Coin Research (internal)
Comments (0)